Danaher had a disappointing 2024. Your path to success next year passes through Wall Street
Life sciences company Danaher certainly hasn't been an easy stock to buy this year. A wave of new companies going…
Porcelain
China investigates NVIDIA for allegedly violating monopoly law
The Chinese government is investigating US chipmaker NVIDIA for allegedly violating its antitrust law by acquiring interconnect provider Mellanox. On…
Opinion: TikTok court case has staggering implications
The free speech implications of the upcoming TikTok ban in the United States are staggering and unprecedented. On Friday, the…
The vicious cycle that could arise from Trump's proposed tariffs
November 30, 2024 3 a.m. Pacific Time To the editor: President-elect Donald Trump proposed rates on products imported from Mexico…
Three Americans imprisoned for years in China arrive in the US
WASHINGTON- Three American citizens imprisoned for years by China returned to the United States on Wednesday night. His release, announced…
We are increasing our price target on GEHC, looking beyond a mixed quarter to next year's catalysts.
GE Healthcare reported a mixed quarter before Wednesday's opening bell. While revenue declined slightly, an improvement in earnings along with…
Merck (MRK) Earnings Q3 2024
The exterior view of the entrance to Merck's headquarters in Rahway, New Jersey, on February 5, 2024. Spencer Platt |…
Danaher puts bioprocessing back into growth. We are raising our rating to buy
Danaher shares fell on Tuesday even though the life sciences company regained growth in its key bioprocessing business in the…
Procter & Gamble (PG) Q1 2025 Earnings
Procter & Gamble It reported weaker-than-expected revenue on Friday as weaker demand in China again hit its sales. The company's…
Ransomware attacks become more dangerous and complex
The number of attempted ransomware attacks on Microsoft customers around the world has increased dramatically over the past year, according…